This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Advice for patients on long-term steroid treatment
February 21, 2022
Adrenal insufficiency
February 4, 2022
Facemask Anxiety
January 5, 2022
Differences between ABPA and CPA
January 5, 2022
The importance of microbiomes
December 16, 2021
Grieving for the life you once had
December 10, 2021
Vaccine Types
November 22, 2021
Vitamin D supplements
November 3, 2021
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video